Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Thursday, November 12, 1998 Published at 01:57 GMT


Health

Obesity epidemic 'ignored'

Obesity is growing in the developed world

Obesity is at epidemic levels in the UK and not enough is being done to combat the disorder, according to research published on Thursday.

In the Pharmaceutical Times report Mark Greener, a former pharmacologist, says money is wasted treating the results of obesity rather than tackling its causes.

"The UK spends around £195m treating obesity-related diseases," he writes.

But only 15% of this goes on tackling obesity itself, he adds.

In the UK, 13% of men and 16% of women are obese, the report says. Overall, 57% of men and 48% of women are overweight.

Obesity can cause heart disease, high blood pressure, cancer and diabetes. It also increases the risk of psychological problems.

The report adds that, on questioning, obese people admit to a worse quality of life than those who have had multiple amputations or who are severely disabled.

Defining the condition

Research has also established that the number of obese people in the developed world has been rising steadily for some time.

Yet effective treatments are hard to come by, according to the report.

There is no consensus on an exact definition of obesity, but doctors agree that it is not the same as simply being overweight.

The main cause of obesity is eating too much combined with a lack of exercise.

Obesity can be seen as the extreme end of a scale that starts at underweight.


[ image:  ]
It is measured using the body mass index (BMI). This is calculated as a person's mass in kilograms divided by the square of their height in metres.

So someone whose mass was 92kg and whose height was 2m would have a BMI of 23 - 92 divided by 4. This falls in the "normal" range on the BMI scale.

The position of the excess fat also makes a difference - fat around the abdomen poses a far higher health risk than fat in the thighs or other parts of the body.

For example, an extra centimetre of fat on the abdomen doubles the risk of heart problems.

Drug treatments

The search for a cure for obesity is big business, but has suffered setbacks.

Last year, two drugs were withdrawn after it was found that they caused heart problems in some patients.

However, a drug launched this year offered new hope for severely overweight patients.

Xenical, the brand name for the drug orlistat, has been available in the UK since September after it won approval from EU regulatory authorities.

The drug works by blocking the digestion of fat in the gut. It has to be taken as part of a low-fat diet. People taking the pill on a high-fat diet will get a bloated and painful stomach and suffer oily diarrhoea.

However, Mr Greener writes: "Orlistat will not be the last drug for obesity, it is too big a problem for that."

Although several other treatments are in development, they will not be ready for many years and the health service will have to focus on encouraging people to adjust their lifestyles, he concludes.





Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

09 Nov 98†|†Health
Obesity and smoking cut brain power

21 Sep 98†|†Health
Fears of stampede over fat-busting drug

26 Aug 98†|†Health
Stomach-stapling tragedy kills obese woman

31 Jul 98†|†Health
Pill gets go-ahead for battle of the bulge

17 Jul 98†|†Health
Successful trial clears way for anti-obesity drug

18 Jun 98†|†Health
America gets fatter





Internet Links


Obesity and health: an overview

Department of Health

Roche (Pharmaceuticals) Obesity Net


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99